6 results
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Regimen for Multi-Drug ... #pharmacology # ... dosing #idsa #drugs ... #steps
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... - IDSA Guidelines ... #Tuberculosis ... #medications #pharmacology ... #Treatment
IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with
multidrug-resistant tuberculosis,
IDSA Summary of ... recommendations on drugs ... regimen for patients ... antimicrobials #pharmacology ... #ebm #idsa
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... Diagnosis: Latent ... Treatment: Active ... #TB #Diagnosis ... #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... Diagnosis: Latent ... Treatment: Active ... #TB #Diagnosis ... #Management #Treatment
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... RAL-based ART regimen ... and molecular diagnostic ... #TB #IDSA #Prevention ... infections #HIVAIDS #pharmacology